These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 12142384)
1. Measurement of prostate-specific antigen by use of a novel blood collection and analytical system. Grzeda BR; Le Bui T; Warner CN; Pirucki TL; Dewey LM; Babich M; Maggiore JA Clin Chem; 2002 Aug; 48(8):1272-8. PubMed ID: 12142384 [TBL] [Abstract][Full Text] [Related]
2. Measurement of circulating forms of prostate-specific antigen in whole blood immediately after venipuncture: implications for point-of-care testing. Piironen T; Nurmi M; Irjala K; Heinonen O; Lilja H; Lövgren T; Pettersson K Clin Chem; 2001 Apr; 47(4):703-11. PubMed ID: 11274021 [TBL] [Abstract][Full Text] [Related]
3. Analytical performance of the Tandem-R free PSA immunoassay measuring free prostate-specific antigen. Woodrum DL; French CM; Hill TM; Roman SJ; Slatore HL; Shaffer JL; York LG; Eure KL; Loveland KG; Gasior GH; Southwick PC; Shamel LB Clin Chem; 1997 Jul; 43(7):1203-8. PubMed ID: 9216457 [TBL] [Abstract][Full Text] [Related]
4. Prostate-specific antigen assay using whole blood samples spotted on filter paper and its application to mass screening for prostate cancer. Nanri M; Nanri K; Fujiyama C; Tokuda Y; Nakamura K; Uozumi J Int J Urol; 2007 Jun; 14(6):505-9. PubMed ID: 17593094 [TBL] [Abstract][Full Text] [Related]
5. In vitro stability of free prostate-specific antigen (PSA) and prostate-specific antigen (PSA) complexed to alpha 1-antichymotrypsin in blood samples. Piironen T; Pettersson K; Suonpää M; Stenman UH; Oesterling JE; Lövgren T; Lilja H Urology; 1996 Dec; 48(6A Suppl):81-7. PubMed ID: 8973706 [TBL] [Abstract][Full Text] [Related]
6. Assay of prostate-specific antigen from whole blood spotted on filter paper and application to prostate cancer screening. Hoffman BR; Yu H; Diamandis EP Clin Chem; 1996 Apr; 42(4):536-44. PubMed ID: 8605670 [TBL] [Abstract][Full Text] [Related]
7. Abbott IMx evaluated for assay of prostate-specific antigen in serum. Dnistrian AM; Schwartz MK; Smith CA; Nisselbaum JS; Fair WR Clin Chem; 1992 Oct; 38(10):2140-2. PubMed ID: 1382898 [TBL] [Abstract][Full Text] [Related]
8. Stability of free prostate-specific antigen in serum samples under a variety of sample collection and sample storage conditions. Woodrum D; French C; Shamel LB Urology; 1996 Dec; 48(6A Suppl):33-9. PubMed ID: 8973697 [TBL] [Abstract][Full Text] [Related]
9. Physiological variation of serum prostate specific antigen in the 4.0 to 10.0 ng./ml. range in male volunteers. Prestigiacomo AF; Stamey TA J Urol; 1996 Jun; 155(6):1977-80. PubMed ID: 8618301 [TBL] [Abstract][Full Text] [Related]
10. Comparison of three assays for total serum prostate-specific antigen and percentage of free prostate-specific antigen in predicting prostate histology. Roehrborn CG; Gregory A; McConnell JD; Sagalowsky AI; Wians FH Urology; 1996 Dec; 48(6A Suppl):23-32. PubMed ID: 8973696 [TBL] [Abstract][Full Text] [Related]
11. Highly sensitive immunoassay of free prostate-specific antigen in serum using europium(III) nanoparticle label technology. Soukka T; Antonen K; Härmä H; Pelkkikangas AM; Huhtinen P; Lövgren T Clin Chim Acta; 2003 Feb; 328(1-2):45-58. PubMed ID: 12559598 [TBL] [Abstract][Full Text] [Related]
12. Determination of alpha1-antichymotrypsin-PSA complex in serum does not improve the differentiation between benign prostatic hyperplasia and prostate cancer compared with total PSA and percent free PSA. Jung K; Brux B; Lein M; Knäbich A; Sinha P; Rudolph B; Schnorr D; Loening SA Urology; 1999 Jun; 53(6):1160-7; discussion 1167-8. PubMed ID: 10367846 [TBL] [Abstract][Full Text] [Related]
13. Methodological and clinical comparison of the ACS prostate-specific antigen assay and the Tandem-E prostate-specific antigen assay in prostate cancer. Schambeck CM; Schmeller N; Stieber P; Jansen HM; Pahl H; Schneider W; Fateh-Moghadam A Urology; 1995 Aug; 46(2):195-9. PubMed ID: 7542821 [TBL] [Abstract][Full Text] [Related]
14. Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial. Catalona WJ; Partin AW; Slawin KM; Brawer MK; Flanigan RC; Patel A; Richie JP; deKernion JB; Walsh PC; Scardino PT; Lange PH; Subong EN; Parson RE; Gasior GH; Loveland KG; Southwick PC JAMA; 1998 May; 279(19):1542-7. PubMed ID: 9605898 [TBL] [Abstract][Full Text] [Related]
15. Determination of prostate-specific antigen in serum by immunoradiometric assay. Lindstedt G; Jacobsson A; Lundberg PA; Hedelin H; Pettersson S; Unsgaard B Clin Chem; 1990 Jan; 36(1):53-8. PubMed ID: 1688745 [TBL] [Abstract][Full Text] [Related]
16. Real-Time quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) for the measurement of prostate-specific antigen mRNA in the peripheral blood of patients with prostate carcinoma using the taqman detection system. Gelmini S; Tricarico C; Vona G; Livi L; Melina AD; Serni S; Cellai E; Magrini S; Villari D; Carini M; Serio M; Forti G; Pazzagli M; Orlando C Clin Chem Lab Med; 2001 May; 39(5):385-91. PubMed ID: 11434386 [TBL] [Abstract][Full Text] [Related]
17. Comparison of 3 investigational assays for the free form of prostate specific antigen. Nixon RG; Meyer GE; Blase AB; Gold MH; Brawer MK J Urol; 1998 Aug; 160(2):420-5. PubMed ID: 9679890 [TBL] [Abstract][Full Text] [Related]
18. The variation of percent free prostate-specific antigen determined by two different assays. Yang CR; Ou YC; Horng YY; Lee HS Anticancer Res; 2003; 23(1B):707-11. PubMed ID: 12680171 [TBL] [Abstract][Full Text] [Related]
20. Analytical evaluation of the new Prostatus PSA Free/Total assay for prostate-specific antigen as part of a screening study for prostate cancer. Blijenberg BG; Bangma CH; Kranse R; Eman I; Schröder FH Eur J Clin Chem Clin Biochem; 1997 Feb; 35(2):111-4. PubMed ID: 9056753 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]